Clinical Significance of Serum Tumor Markers Level in Patients with NSCLC

SHI Min-hua,HU Jun-zhu,HU Hua-cheng
DOI: https://doi.org/10.3969/j.issn.1673-0399.2001.02.015
2001-01-01
Abstract:Objective To investigate the role of tumor markers in the diagnosis, pathological classification, progression and therapeutic efficiency evaluation in patients with NSCLC.Methods Serum levels of TSGF, CEA and CYFRA21-1 in 98 patients with NSCLC in different TMN stages were determined with chromatometry, chemoluminescence and ELISA methods respectively.Results It was found that TSGF increased in the most patients with lung cancer in various stages as well as in patients with acute inflammation. Serum concentrations of CEA and CYFRA21-1 were higher in adenocarcinoma and squamous carcinoma respectively than that of other subtypes and increased with the progress of clinical stages.High serum levels of TSGF, CEA, CYFRA21-1 could be seen in patients with more advanced stages of NSCLC, which might indicate a heavy tumor burden.Conclusion A combined analysis of serum levels of TSGF, CEA, CYFRA21-1 in addition to other clinical and accessory examinations may contribute to the early diagnosis, pathological classification, recurrence monitoring and prognosis evaluation of NSCLC.
What problem does this paper attempt to address?